Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial
Adults taking a GLP-1 medication who want a convenient daily multivitamin
Lowe TL, Cohen DJ, Miller S, Young JG: Folic acid and B 12 in autism and neuropsychiatric disturbances of childhood
Are some people at higher risk for dehydration on GLP-1 treatments
While individual responses vary, here is a general timeline based on clinical observations: It is worth emphasizing that these timelines assume you are using a properly dosed, human-grade peptide under medical supervision
Tirzepatide 15 mg vs cagrilintide/semaglutide (CagriSema): The combination of cagrilintide and semaglutide adds amylin receptor agonism to GLP-1 activation